×
Sera Prognostics EBIT 2021-2024 | SERA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sera Prognostics ebit from 2021 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Sera Prognostics EBIT 2021-2024 | SERA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sera Prognostics ebit from 2021 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$88.4B
Cencora (COR)
$45.7B
Natera (NTRA)
$23.1B
DiDi Global (DIDIY)
$22B
ICON (ICLR)
$18B
Avantor (AVTR)
$14.7B
Viatris (VTRS)
$13.9B
Revvity (RVTY)
$13.9B
BioMerieux (BMXMF)
$12.6B
CochLear (CHEOY)
$12.1B
Solventum (SOLV)
$11.6B
Medpace Holdings (MEDP)
$10.9B
Doximity (DOCS)
$9.7B
EUROFINS SCIENT (ERFSF)
$9.7B
Charles River Laboratories (CRL)
$9.5B
HealthEquity (HQY)
$8.7B
Sonic Healthcare (SKHHY)
$8.2B
Bausch + Lomb (BLCO)
$6.3B
Amplifon S.p.A (AMFPF)
$5.9B
Organon (OGN)
$4.1B
Sotera Health (SHC)
$3.7B
BrightSpring Health Services (BTSG)
$3B
Surgery Partners (SGRY)
$2.6B
Concentras Parent (CON)
$2.5B
GeneDx Holdings (WGS)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2B
PACS (PACS)
$2B
GoodRx Holdings (GDRX)
$1.7B